Comparing radiation side effects for early stage prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study compares two types of radiation therapy for low- to intermediate-risk prostate cancer. One uses tiny radioactive seeds placed inside the prostate (brachytherapy), the other uses very high doses of external radiation over fewer sessions. The goal is to see which has fewer side effects while still being effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man over 18 years old
- You have low- or intermediate-risk prostate cancer (Gleason 3+3 or 3+4)
- Your PSA level is 20 or less
- Your cancer is still within the prostate (stage T1 to T2, no spread seen on scans)
- You have not had prior radiation or hormone therapy for your prostate cancer
- You do not have severe urinary symptoms or a very large prostate (over 60 cc)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a lower dose of radiation can effectively treat prostate cancer while reducing side effects. It is for men with certain types of prostate cancer that are visible on an MRI.
This trial tests whether a shorter course of radiation works as well as the usual longer course for people with high-risk prostate cancer. The goal is to keep cancer control while possibly reducing treatment time and inconvenience.
This trial studies a combination of two radiation types—high-dose-rate brachytherapy and stereotactic body radiotherapy—to treat certain intermediate- to high-risk prostate cancers. It may help by aiming radiation closely at the prostate while also targeting the cancer from outside the body.
This trial compares two types of radiation therapy (SBRT and LDR brachytherapy) for men with low-risk or favorable intermediate-risk prostate cancer. The goal is to see which treatment causes fewer side effects.
This trial studies how safe and effective different high-dose radiation levels are for prostate cancer placed directly in the prostate (HDR brachytherapy). It may help by finding a dose that controls the cancer while keeping side effects acceptable.
This study compares two radiation treatments—seed brachytherapy and stereotactic body radiotherapy—to see which better preserves erections in men with early- to mid-risk prostate cancer. It’s designed to help patients understand how different curative radiation choices can affect sexual function.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.